BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27561105)

  • 1. Calreticulin is highly expressed in pancreatic cancer stem-like cells.
    Matsukuma S; Yoshimura K; Ueno T; Oga A; Inoue M; Watanabe Y; Kuramasu A; Fuse M; Tsunedomi R; Nagaoka S; Eguchi H; Matsui H; Shindo Y; Maeda N; Tokuhisa Y; Kawano R; Furuya-Kondo T; Itoh H; Yoshino S; Hazama S; Oka M; Nagano H
    Cancer Sci; 2016 Nov; 107(11):1599-1609. PubMed ID: 27561105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
    J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes.
    Fujimoto T; Tsunedomi R; Matsukuma S; Yoshimura K; Oga A; Fujiwara N; Fujiwara Y; Matsui H; Shindo Y; Tokumitsu Y; Suzuki N; Kobayashi S; Hazama S; Eguchi H; Nagano H
    Oncol Lett; 2021 Jan; 21(1):30. PubMed ID: 33240436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance.
    Fujiwara Y; Tsunedomi R; Yoshimura K; Matsukuma S; Fujiwara N; Nishiyama M; Kanekiyo S; Matsui H; Shindo Y; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
    Pancreas; 2021 Mar; 50(3):405-413. PubMed ID: 33835973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological significance of the expression of calreticulin in human pancreatic cancer].
    Sheng WW; Dong M; Zhou JP; Li X; Dong Q
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):58-61. PubMed ID: 23578430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer.
    Bao B; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Aboukameel A; Mohammad R; Van Buren E; Azmi AS; Sarkar FH
    Stem Cells Dev; 2014 Aug; 23(16):1947-58. PubMed ID: 24734907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro.
    Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M; Morisaki T
    Anticancer Res; 2014 Aug; 34(8):4509-19. PubMed ID: 25075094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.
    Sheng W; Chen C; Dong M; Wang G; Zhou J; Song H; Li Y; Zhang J; Ding S
    Cell Death Dis; 2017 Oct; 8(10):e3147. PubMed ID: 29072694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.
    Kakehashi A; Ishii N; Sugihara E; Gi M; Saya H; Wanibuchi H
    Cancer Sci; 2016 May; 107(5):609-18. PubMed ID: 26882440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
    Sheng W; Chen C; Dong M; Zhou J; Liu Q; Dong Q; Li F
    J Cell Physiol; 2014 Jul; 229(7):887-97. PubMed ID: 24264800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
    Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
    EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
    Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
    Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.
    Chao MP; Jaiswal S; Weissman-Tsukamoto R; Alizadeh AA; Gentles AJ; Volkmer J; Weiskopf K; Willingham SB; Raveh T; Park CY; Majeti R; Weissman IL
    Sci Transl Med; 2010 Dec; 2(63):63ra94. PubMed ID: 21178137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis.
    Abbasian M; Mousavi E; Arab-Bafrani Z; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8192-8202. PubMed ID: 30317669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer stem cells: fact or fiction?
    Bhagwandin VJ; Shay JW
    Biochim Biophys Acta; 2009 Apr; 1792(4):248-59. PubMed ID: 19233264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma.
    Wang JH; Huang ST; Zhang L; Liu ZG; Liang RX; Jiang SW; Jiang YN; Yu XJ; Jiang YC; Li XZ; Zhang PF; Wen ZS; Zheng M
    Cancer Med; 2019 Mar; 8(3):1315-1325. PubMed ID: 30741466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
    Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
    Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.